Suzhou Industrial Park Heshun Electric
300141
Guangdong Xiongsu Technology Group
300599
Sichuan Chuanhuan Technology
300547
Shanghai Wisdom Information Technology
301315
KANGNONG SEED
837403
CN Stock MarketDetailed Quotes
301096 Hangzhou Bio-Sincerity Pharma-Tech
- 39.77
- +0.07+0.18%
Market Closed Dec 27 15:00 CST
4.34BMarket Cap20.48P/E (TTM)
40.07High39.32Low17.42KlotVolume39.73Open39.70Pre Close69.20MTurnover2.51%Turnover Ratio15.97P/E (Static)109.23MShares77.4852wk High1.57P/B2.76BFloat Cap33.5752wk Low47.64Limit Up69.43MShs Float118.30Historical High31.76Limit Down1.89%Amplitude33.57Historical Low0.30Dividend TTM39.73Avg Price8.63KlotAsk0.75%Div YieldTTM100Lot Size8.50KlotBid
Hangzhou Bio-Sincerity Pharma-Tech Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 1.07%721.48M | 23.88%525.06M | 34.04%215.7M | 67.51%1.02B | 69.65%713.81M | 72.53%423.86M | 67.97%160.92M | 62.27%607.41M | 89.26%420.74M | 73.91%245.67M |
| Operating revenue | 1.07%721.48M | 23.88%525.06M | 34.04%215.7M | 67.51%1.02B | 69.65%713.81M | 72.53%423.86M | 67.97%160.92M | 62.27%607.41M | 89.26%420.74M | 73.91%245.67M |
| Other operating revenue | ---- | --0 | ---- | --111.11K | ---- | --0 | ---- | --0 | ---- | --0 |
| Total operating cost | 21.10%580.69M | 33.98%384.88M | 30.67%164.55M | 64.56%714.53M | 75.21%479.52M | 72.65%287.27M | 56.00%125.93M | 67.17%434.2M | 82.73%273.68M | 72.81%166.38M |
| Operating cost | 20.09%280.15M | 15.75%164.07M | 24.29%68.61M | 76.98%350.74M | 83.36%233.29M | 67.66%141.74M | 74.43%55.2M | 61.74%198.18M | 75.26%127.23M | 79.47%84.54M |
| Operating tax surcharges | 130.57%7.41M | 312.20%5.03M | 1,714.38%2.43M | 128.88%5.7M | 113.09%3.21M | 128.00%1.22M | -126.58%-150.76K | 332.87%2.49M | 368.43%1.51M | 182.49%535.42K |
| Operating expense | 67.98%11.34M | 59.94%6.88M | -34.67%1.47M | 23.08%9.65M | 32.86%6.75M | 24.66%4.3M | 39.06%2.25M | 16.90%7.84M | 89.17%5.08M | 126.44%3.45M |
| Administration expense | -54.20%45.4M | 0.77%61.73M | -6.95%28.05M | 26.82%128.63M | 66.97%99.13M | 106.77%61.26M | 116.60%30.14M | 111.76%101.43M | 89.17%59.37M | 59.51%29.63M |
| Financial expense | 107.92%1.33M | 88.47%-1.51M | 79.17%-1.28M | 49.28%-21.21M | 49.17%-16.83M | 41.81%-13.06M | 44.22%-6.16M | -4,845.03%-41.81M | -2,912.60%-33.12M | -4,636.10%-22.45M |
| -Interest expense (Financial expense) | 173.75%12.11M | 213.43%7.77M | 2,063.42%3.43M | 438.83%7.11M | 348.79%4.42M | 172.17%2.48M | -80.20%158.75K | -64.00%1.32M | 186.50%985.61K | 164.76%910.82K |
| -Interest Income (Financial expense) | 49.08%-10.91M | 40.39%-9.36M | 25.53%-4.76M | 32.20%-28.48M | 34.82%-21.43M | 30.22%-15.71M | 43.18%-6.39M | -1,749.73%-42.01M | -4,669.58%-32.88M | -7,425.68%-22.51M |
| Research and development | 52.66%235.05M | 61.94%148.68M | 46.22%65.27M | 45.13%241.02M | 35.53%153.97M | 29.89%91.81M | 1.42%44.64M | 104.68%166.07M | 167.37%113.6M | 141.82%70.68M |
| Credit Impairment Loss | -284.65%-13.86M | -238.74%-10.36M | -8.54%-1.9M | -38.11%-9.86M | -7.14%-3.6M | -322.42%-3.06M | -49.88%-1.75M | -126.61%-7.14M | -63.35%-3.36M | 37.31%-723.96K |
| Asset Impairment Loss | 17.64%-6.25M | -40.35%-8.76M | -72.74%-2.67M | -342.41%-12.91M | -179.00%-7.59M | -521.27%-6.24M | -228.85%-1.55M | -101.20%-2.92M | -172.76%-2.72M | -118.64%-1M |
| Other net revenue | -16.21%-9.95M | 16.10%-6.24M | -27.56%-3.34M | -138.23%-5.9M | -325.38%-8.56M | -872.93%-7.44M | -247.44%-2.62M | 250.07%15.43M | 2.04%-2.01M | 233.33%962.37K |
| Fair value change income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2.92M | ---2.92M | ---2.92M |
| Invest income | -6,331.89%-6.59M | 23.10%130.09K | --31.27K | 89.78%-107.91K | 110.01%105.68K | 113.81%105.68K | ---- | -62.29%-1.06M | -208.65%-1.06M | -178.36%-765.36K |
| -Including: Investment income associates | ---6.91M | --72.03K | --31.27K | 113.33%102.05K | ---- | ---- | ---- | 15.63%-765.36K | -27.86%-765.36K | -81.88%-765.36K |
| Asset deal income | ---- | ---- | ---- | 5,050.07%780.71K | --958.06K | --968.78K | ---- | --15.16K | ---- | ---- |
| Other revenue | 966.69%16.75M | 1,524.17%12.75M | 77.16%1.2M | -44.99%16.2M | -80.48%1.57M | -87.68%784.74K | -88.87%674.9K | 204.83%29.44M | 498.61%8.04M | 445.88%6.37M |
| Operating profit | -42.04%130.83M | 3.71%133.94M | 47.67%47.81M | 57.45%297.02M | 55.62%225.72M | 60.95%129.16M | 92.02%32.37M | 58.54%188.64M | 105.81%145.05M | 81.30%80.25M |
| Add:Non operating Income | -11.63%281.68K | -13.88%165.26K | 306.92%93.54K | -84.16%384.7K | -96.68%318.74K | -98.00%191.9K | -36.04%22.99K | 1,567.96%2.43M | 7,621.97%9.61M | 12,546.08%9.57M |
| Less:Non operating expense | -76.19%400.26K | -99.90%1.56K | -95.31%1.51K | 941.31%1.73M | 934.56%1.68M | 1,149.98%1.64M | -70.54%32.18K | -11.53%165.84K | -13.30%162.52K | -23.64%131.08K |
| Total profit | -41.74%130.72M | 5.01%134.11M | 48.00%47.9M | 54.88%295.68M | 45.22%224.36M | 42.39%127.71M | 92.80%32.36M | 60.50%190.91M | 119.41%154.49M | 103.08%89.69M |
| Less:Income tax cost | -147.41%-10.82M | -100.77%-63.17K | 30.05%-1.92M | 854.40%23.66M | 144.70%22.83M | 73.38%8.21M | -1.25%-2.75M | -139.32%-3.14M | 56.02%9.33M | 44.74%4.73M |
| Net profit | -29.77%141.54M | 12.28%134.17M | 41.89%49.82M | 40.18%272.01M | 38.83%201.53M | 40.67%119.5M | 80.07%35.11M | 74.86%194.04M | 125.29%145.16M | 107.74%84.95M |
| Net profit from continuing operation | -29.77%141.54M | 12.28%134.17M | 41.89%49.82M | 40.18%272.01M | 38.83%201.53M | 40.67%119.5M | 80.07%35.11M | 74.86%194.04M | 125.29%145.16M | 107.74%84.95M |
| Less:Minority Profit | -388.72%-118.51K | -195.03%-39.01K | ---- | 140.02%48.56K | 170.14%41.05K | 161.07%41.05K | 229.26%41.05K | -2.17%-121.35K | 30.28%-58.53K | -20.93%-67.21K |
| Net profit of parent company owners | -29.69%141.66M | 12.35%134.21M | 42.06%49.82M | 40.07%271.97M | 38.74%201.49M | 40.51%119.46M | 79.56%35.07M | 74.78%194.16M | 125.08%145.22M | 107.62%85.02M |
| Earning per share | ||||||||||
| Basic earning per share | -29.57%1.31 | 12.73%1.24 | 43.75%0.46 | 39.44%2.51 | 38.81%1.86 | 39.24%1.1 | 77.78%0.32 | 31.39%1.8 | 67.50%1.34 | 58.00%0.79 |
| Diluted earning per share | -29.57%1.31 | 12.73%1.24 | 43.75%0.46 | 40.22%2.51 | 38.81%1.86 | 39.24%1.1 | 77.78%0.32 | 30.66%1.79 | 67.50%1.34 | 58.00%0.79 |
| Other composite income | 103.55%2.25K | 99.17%-507.93 | -1.35K | -136.19K | -63.25K | -61.14K | ||||
| Other composite income of parent company owners | 103.55%2.25K | 99.17%-507.93 | ---1.35K | ---136.19K | ---63.25K | ---61.14K | ---- | ---- | ---- | ---- |
| Total composite income | -29.74%141.54M | 12.33%134.17M | 41.89%49.82M | 40.11%271.88M | 38.79%201.47M | 40.59%119.44M | 80.07%35.11M | 74.86%194.04M | 125.29%145.16M | 107.74%84.95M |
| Total composite income of parent company owners | -29.67%141.66M | 12.40%134.21M | 42.06%49.82M | 40.00%271.83M | 38.70%201.42M | 40.44%119.4M | 79.56%35.07M | 74.78%194.16M | 125.08%145.22M | 107.62%85.02M |
| Total composite income of minority owners | -388.72%-118.51K | -195.03%-39.01K | ---- | 140.02%48.56K | 170.14%41.05K | 161.07%41.05K | 229.26%41.05K | -2.17%-121.35K | 30.28%-58.53K | -20.93%-67.21K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
